AC Immune SA
ACIU
$2.85
-$0.10-3.38%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 14.13% | 5.99% | 5.99% | 4.87% |
| Total Depreciation and Amortization | -- | 6.41% | 0.59% | 0.59% | -0.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -82.84% | 58.74% | 58.74% | 2.68% |
| Change in Net Operating Assets | -- | -96.05% | 1,731.75% | 1,731.75% | 799.81% |
| Cash from Operations | -- | -201.75% | 204.92% | 204.92% | 207.63% |
| Capital Expenditure | -- | -33.35% | 19.33% | 19.33% | 26.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 134.09% | -101,505.99% | -101,505.99% | -260.04% |
| Cash from Investing | -- | 132.28% | -8,234.19% | -8,234.19% | -262.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -37.70% | -32.59% | -32.59% | -24.64% |
| Issuance of Common Stock | -- | -99.99% | -99.69% | -99.69% | -99.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 99.81% | 94.20% | 94.20% | -- |
| Cash from Financing | -- | -102.20% | -101.62% | -101.62% | -102.62% |
| Foreign Exchange rate Adjustments | -- | -56.17% | -1,978.45% | -1,978.45% | -2.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -325.00% | -7,989.77% | -7,989.77% | -192.98% |